Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03026816 · ClinicalTrials.gov registry record · NA

Epidural Stimulation After Neurologic Damage

A NA study of Spinal Cord Injuries and Paraplegia, Complete, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03026816 is a NA study of Spinal Cord Injuries and Paraplegia, Complete that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 100 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (64% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03026816, a NA study of Spinal Cord Injuries and Paraplegia, Complete, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate a method to optimize parameter settings in epidural spinal cord stimulation used to recover lower extremity volitional movement. The study will also characterize improvement in autonomic function (such as blood pressure control) and other functions related to spinal cord injury.

Interventions

  • DEVICE Epidural Spinal Cord Stimulation

Study Locations (1)

Minnesota

  • Hennepin County Medical Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2017-08-07
Est. Completion 2028-01
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT03026816

The ClinicalTrials.gov registry entry for NCT03026816 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (64% higher). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Epidural Spinal Cord Stimulation is the first listed.

NCT03026816 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03026816 about?

NCT03026816 is a clinical study titled "Epidural Stimulation After Neurologic Damage". This study will evaluate a method to optimize parameter settings in epidural spinal cord stimulation used to recover lower extremity volitional movement. The study will also characterize improvement in autonomic function (such as blood pressure control) and other functions related to spinal cord inj...

What is the current status of trial NCT03026816?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2017-08-07. Estimated completion is 2028-01.

What conditions does trial NCT03026816 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Paraplegia, Complete.

What interventions are being tested in trial NCT03026816?

The interventions under investigation include: Epidural Spinal Cord Stimulation (DEVICE).

Who is sponsoring clinical trial NCT03026816?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03026816 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.